206 related articles for article (PubMed ID: 24167568)
1. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
2. The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.
Sato S; Trackman PC; Mäki JM; Myllyharju J; Kirsch KH; Sonenshein GE
Mol Cell Biol; 2011 Jul; 31(13):2683-95. PubMed ID: 21536655
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.
Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I
J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286
[TBL] [Abstract][Full Text] [Related]
4. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
5. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
6. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
[TBL] [Abstract][Full Text] [Related]
7. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
Min C; Yu Z; Kirsch KH; Zhao Y; Vora SR; Trackman PC; Spicer DB; Rosenberg L; Palmer JR; Sonenshein GE
Cancer Res; 2009 Aug; 69(16):6685-93. PubMed ID: 19654310
[TBL] [Abstract][Full Text] [Related]
8. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
9. SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
Feng L; Wang JT; Jin H; Qian K; Geng JG
Cell Biochem Funct; 2011 Oct; 29(7):589-96. PubMed ID: 21830225
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
11. CIN85 interacting proteins in B cells-specific role for SHIP-1.
Büchse T; Horras N; Lenfert E; Krystal G; Körbel S; Schümann M; Krause E; Mikkat S; Tiedge M
Mol Cell Proteomics; 2011 Oct; 10(10):M110.006239. PubMed ID: 21725061
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.
Kedar VP; Darby MK; Williams JG; Blackshear PJ
PLoS One; 2010 Mar; 5(3):e9588. PubMed ID: 20221403
[TBL] [Abstract][Full Text] [Related]
13. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.
Sánchez-Morgan N; Kirsch KH; Trackman PC; Sonenshein GE
J Cell Biochem; 2017 Aug; 118(8):2347-2356. PubMed ID: 28106301
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
[TBL] [Abstract][Full Text] [Related]
15. The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis.
Zheng X; Zhang J; Liao K
BMC Biochem; 2014 Jul; 15():13. PubMed ID: 25005938
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.
Li Q; Yang W; Wang Y; Liu W
Biochemistry; 2018 Apr; 57(14):2132-2139. PubMed ID: 29589748
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer.
de la Cueva A; Emmerling M; Lim SL; Yang S; Trackman PC; Sonenshein GE; Kirsch KH
Carcinogenesis; 2018 Jul; 39(7):921-930. PubMed ID: 29579155
[TBL] [Abstract][Full Text] [Related]
19. Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.
Minegishi Y; Shibagaki Y; Mizutani A; Fujita K; Tezuka T; Kinoshita M; Kuroda M; Hattori S; Gotoh N
Cancer Sci; 2013 Mar; 104(3):345-52. PubMed ID: 23279575
[TBL] [Abstract][Full Text] [Related]
20. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
